Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biofrontera Ag ADR (BFRA)

Biofrontera Ag ADR (BFRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biofrontera Ag ADR HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 DEU

www.biofrontera.com P: 011-49-2148-7600

Description:

Biofrontera AG is a biopharmaceutical company. It engaged in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions and diseases. The company's products focus on the treatment in the U.S. and Europe of actinic keratoses, which are skin lesions which can sometimes lead to skin cancer as well as the treatment of certain forms of basal cell carcinoma in the European Union. Biofrontera AG is based in Leverkusen, Germany.

Key Statistics

Overview:

Market Capitalization, $K 75,719
Shares Outstanding, K 28,359
Annual Sales, $ 34,660 K
Annual Net Income, $ -14,880 K
Last Quarter Sales, $ 6,340 K
Last Quarter Net Income, $ -6,840 K
60-Month Beta 1.02
% of Institutional Shareholders 60.07%
Float, K 28,359
% Float 100.00%

Growth:

1-Year Return -54.82%
3-Year Return -80.37%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 04/11/22
Earnings Per Share ttm -0.73
EPS Growth vs. Prev Qtr -41.18%
EPS Growth vs. Prev Year 14.29%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BFRA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -93.31%
Return-on-Assets % -24.03%
Profit Margin % -42.93%
Debt/Equity 0.13
Price/Sales 2.47
Price/Cash Flow N/A
Price/Book 4.04
Book Value/Share 0.66
Interest Coverage -3.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar